Literature DB >> 18355658

Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT study.

Mary F Walter1, Robert F Jacob, Rebekah E Bjork, Barrett Jeffers, Jan Buch, Yoshiko Mizuno, R Preston Mason.   

Abstract

OBJECTIVES: This study was designed to determine the predictive value of lipid hydroperoxide (LOOH) levels for adverse cardiovascular outcomes in patients with stable coronary artery disease (CAD).
BACKGROUND: Oxidative modification of circulating lipids contributes to inflammation and endothelial dysfunction, which are hallmark features of atherosclerosis. A serum biomarker of oxidation is LOOH, which is a primary product of fatty acid peroxidation.
METHODS: Serum LOOH levels were measured and correlated with clinical events over a 3-year period in 634 patients with angiographic evidence of CAD.
RESULTS: Baseline LOOH levels in the highest quartile were associated with hazard ratios of 3.24 (95% confidence interval [CI] 1.86 to 5.65; p = 0.0001) for nonfatal vascular events (n = 149), 1.80 (95% CI 1.13 to 2.88; p = 0.014) for major vascular procedures (n = 139), and 2.23 (95% CI 1.44 to 3.44; p = 0.0003) for all vascular events and procedures. Baseline LOOH levels correlated with serum levels of soluble intercellular adhesion molecule-1 (p = 0.001) and thiobarbituric acid reactive substances (p = 0.001) as well as the mean percent change in stenosis for large segments >50% stenosed (p = 0.048). A multivariate proportional hazards model, adjusted for traditional risk factors and inflammatory markers, showed an independent effect of LOOH on nonfatal vascular events, vascular procedures, and all events or procedures. Amlodipine treatment was associated with reduced cardiovascular events and changes in LOOH levels compared with placebo.
CONCLUSIONS: Elevated LOOH levels were predictive of nonfatal vascular events and procedures in patients with stable CAD, independent of traditional risk factors and inflammatory markers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355658     DOI: 10.1016/j.jacc.2007.11.051

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

Review 1.  Antioxidants and coronary artery disease: from pathophysiology to preventive therapy.

Authors:  Jane A Leopold
Journal:  Coron Artery Dis       Date:  2015-03       Impact factor: 1.439

2.  Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction.

Authors:  Margarete Dulce Bagatini; Caroline Curry Martins; Vanessa Battisti; Diogo Gasparetto; Cintia Saydelles da Rosa; Roselia Maria Spanevello; Mushtaq Ahmed; Roberta Schmatz; Maria Rosa Chitolina Schetinger; Vera Maria Morsch
Journal:  Heart Vessels       Date:  2010-10-27       Impact factor: 2.037

3.  Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats.

Authors:  Zhenghao Zhang; Geeta Datta; Yun Zhang; Andrew P Miller; Paulina Mochon; Yiu-Fai Chen; John Chatham; G M Anantharamaiah; C Roger White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-26       Impact factor: 4.733

4.  Oxidized high-density lipoprotein impairs endothelial progenitor cells' function by activation of CD36-MAPK-TSP-1 pathways.

Authors:  Jianxiang Wu; Zhiqing He; Xiang Gao; Feng Wu; Ru Ding; Yusheng Ren; Qijun Jiang; Min Fan; Chun Liang; Zonggui Wu
Journal:  Antioxid Redox Signal       Date:  2014-12-02       Impact factor: 8.401

5.  Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia.

Authors:  Alexina Orsoni; Patrice Thérond; Ricardo Tan; Philippe Giral; Paul Robillard; Anatol Kontush; Peter J Meikle; M John Chapman
Journal:  J Lipid Res       Date:  2016-08-31       Impact factor: 5.922

Review 6.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

Review 7.  Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association.

Authors:  Kathy K Griendling; Rhian M Touyz; Jay L Zweier; Sergey Dikalov; William Chilian; Yeong-Renn Chen; David G Harrison; Aruni Bhatnagar
Journal:  Circ Res       Date:  2016-07-14       Impact factor: 17.367

Review 8.  Cardio-Protective Properties and Health Benefits of Fish Lipid Bioactives; The Effects of Thermal Processing.

Authors:  Alexandros Tsoupras; Chloe Brummell; Ciara Kealy; Karolis Vitkaitis; Shane Redfern; Ioannis Zabetakis
Journal:  Mar Drugs       Date:  2022-03-02       Impact factor: 5.118

Review 9.  Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations.

Authors:  R Lee; M Margaritis; K M Channon; C Antoniades
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

10.  Reactive oxygen metabolites are closely associated with the diagnosis and prognosis of coronary artery disease.

Authors:  Yoshihiro Hirata; Eiichiro Yamamoto; Takanori Tokitsu; Hiroaki Kusaka; Koichiro Fujisue; Hirofumi Kurokawa; Koichi Sugamura; Hirofumi Maeda; Kenichi Tsujita; Koichi Kaikita; Seiji Hokimoto; Seigo Sugiyama; Hisao Ogawa
Journal:  J Am Heart Assoc       Date:  2015-01-28       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.